MiNK Therapeutics INKT
NASDAQ INKT
$10.06 -0.56 (-5.27%)
At close: Oct 22, 2026 · 4:00 PM EDT

MiNK Therapeutics (INKT) Non-Current Debt (2024)

Updated

MiNK Therapeutics (INKT) posted Non-Current Debt of $4.92 million for Q4 2024, up 6.8% from the prior quarter.

Analysis

MiNK Therapeutics (INKT) Non-Current Debt (2024) Analysis & Trends

Since Q1 2024, MiNK Therapeutics has reported Non-Current Debt for 4 quarters.

  • According to Business Quant data, Non-Current Debt for the three prior quarters was $4.61 million (Q3 2024), $4.41 million (Q2 2024) and $4.21 million (Q1 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 35.80 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 62.48 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 23.68 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 23.83 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 60.50 Bn
10 MiNK Therapeutics 51.69 Mn 10.50 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 4.92 Mn
Sep 30, 2024 4.61 Mn
Jun 30, 2024 4.41 Mn
Mar 31, 2024 4.21 Mn
API Access

MiNK Therapeutics Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=INKT&period=max&api_key=YOUR_API_KEY